- An Obesity Drug Prevents Covid Deaths, Study Suggests The New York Times
- Ozempic and Wegovy cut risk of severe COVID in people with obesity, says Harvard study The Boston Globe
- Wegovy Protects Against Deadly COVID Cases Medpage Today
- New Wegovy analysis could boost Novo Nordisk’s bid to expand drug’s label in heart failure STAT
- Novo builds heart failure case for semaglutide; Ventyx CFO departs Yahoo Finance
An Obesity Drug Prevents Covid Deaths, Study Suggests – The New York Times
Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp
